Last edition
News about "HDAC inhibitor "
FDA Grants Approval to PPMD DUVYZAT for Duchenne Patients
Parent Project Muscular Dystrophy has been granted approval of DUVYZAT (givinostat) a histone deacetylase (HDAC) inhibitor indicated for individuals diagnosed with Duchenne six years of age and older by FDA.
HDAC Inhibitor | 22/03/2024 | By Manvi | 728
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members